Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states 2025-08-27 20:00
Innovent Announces 2025 Interim Results and Business Updates 2025-08-27 18:08
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum 2025-08-27 14:02
iNtRON Bio, files Two Patent Applications for IMPA™ Platform-Based Gene Editing Technology 2025-08-26 21:00
Fosun Pharma Announces 2025 Interim Results 2025-08-26 20:42
Peijia Medical Announces 2025 Interim Results 2025-08-25 20:00
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints 2025-08-25 13:46
Harbour BioMed Appoints Yajie Li as Chief Medical Officer 2025-08-25 09:00
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer 2025-08-25 08:00
BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization 2025-08-21 20:00
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health 2025-08-21 20:00
GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE-Indexed Journal 2025-08-21 13:00
Cell therapy is promising in treating psychiatric disorders, such as depression. -- A proof-of-principle study published in "Cell Stem Cell" by the laboratory of Dr. Chen, founder of UniXell Biotech, suggests this. 2025-08-20 20:49
Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from FDA 2025-08-19 22:00
WuXi Biologics Reports Solid 2025 Interim Results 2025-08-19 20:35
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company 2025-08-18 20:00
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies 2025-08-18 12:40
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity 2025-08-18 08:15
GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation 2025-08-17 20:01
Novel Gene Therapy for ALS cleared for global trials in China and the U.S. 2025-08-15 19:00